Comparison of 2 analytical methods of DCE-MRI in advanced NSCLC patients treated with erlotinib and bevacizumab

V.E.M. van den Boogaart, W. Backes, A.J. de Langen, P. Leffers, H.J.M. Groen, J.T. Marcus, P. Kappert, E.F. Smit, A.C. Dingemans

Research output: Contribution to journalMeeting AbstractOther research output

Original languageUndefined/Unknown
Pages (from-to)S747-S747
JournalJournal of Thoracic Oncology
Volume4
Issue number9
Publication statusPublished - 2009

Cite this

van den Boogaart, V. E. M., Backes, W., de Langen, A. J., Leffers, P., Groen, H. J. M., Marcus, J. T., ... Dingemans, A. C. (2009). Comparison of 2 analytical methods of DCE-MRI in advanced NSCLC patients treated with erlotinib and bevacizumab. Journal of Thoracic Oncology, 4(9), S747-S747.